WHO Lists First Molecular Diagnostic Test for Bundibugyo Virus Under Emergency Use Listing for DRC Outbreak

ISRO Launches EOS-05: India's First Geo-Imaging Satellite in Geosynchronous Orbit; SC Invokes Article 142 to Quash CJP Protest Cases

A day of high exam relevance: ISRO successfully launched EOS-05, India’s first dedicated geo-imaging satellite in geosynchronous orbit, breaking a failure streak. The Supreme Court used its extraordinary power under Article 142 to close cases linked to CJP protests, raising important constitutional questions. Other key updates include OpenAI’s new autonomous AI model, Manipur’s NRC-first demand for Census deferral, mistrust in GDP data, and Tata Chemicals’ Kenya dispute.

EU Data Regulator Fines Google €403 Million for Location Data Violations Under GDPR

Ireland's Data Protection Commission (DPC) fined Google €403 million ($463 million) for unlawful processing of user location data. This is the fourth-largest fine by the Irish watchdog, highlighting the EU's strict enforcement of GDPR and its implications for global tech firms operating in Europe.

Meta Trial: $567 Mn Penalty for Child Addiction, 29-State Probe on Social Media Design

A US trial against Meta over addictive social media design for children could reshape Big Tech accountability. With penalties of $567 million and a $6 million jury verdict, this case highlights the growing scrutiny of platform design and its impact on youth mental health, a key issue for GS2 (Social Justice) and GS3 (Technology).

EU Proposes Ban on Social Media & AI Chatbots for Under-15s Under EU Kids Act

The European Commission will propose sweeping restrictions on under-15s' access to social media, AI chatbots, and online games as part of a new EU Kids Act. The proposal includes age-gated access tiers, mandatory parental controls, addiction prevention, and a supervisory fee on tech companies. This signals a major global regulatory shift on child online safety with implications for digital governance frameworks.

India Gets First Disease-Modifying Alzheimer's Drug Leqembi After CDSCO Nod

Eisai's Leqembi (lecanemab), India's first disease-modifying therapy for early Alzheimer's, has been launched after CDSCO approval. This marks a shift from symptomatic to disease-modifying treatment, but challenges of early diagnosis, biomarker infrastructure, and affordability remain significant.

US FDA Approves First mRNA Flu Shot mFlusiva for Adults 50+ with 26.6% Higher Efficacy

US FDA has approved Moderna's mFlusiva, the first mRNA-based flu vaccine, for adults aged 50 and older. The vaccine demonstrated 26.6% higher efficacy than standard flu shots in a large late-stage trial. This marks a milestone in mRNA technology beyond COVID-19 and is a key topic for Science & Tech and Health sections.

NASA Invites ISRO to Join Moon Base Program Under Artemis Accords for Lunar South Pole Outpost

NASA has formally invited ISRO to join its ambitious Moon Base programme, aiming to build humanity's first lunar outpost near the South Pole. This invitation, extended during the 9th India-U.S. Civil Space Joint Working Group meeting in Bengaluru, deepens bilateral space collaboration under the Artemis Accords and the TRUST initiative. For UPSC aspirants, this is a crucial topic for Science & Tech and International Relations, with potential prelims questions on the Artemis Accords, CSJWG, and lunar South Pole.

IISc SraVaani: India's First Open-Source Speech Recognition Model for 65 Languages

IISc's SPIRE Lab, in collaboration with ARTPARK and Google, has released SraVaani – the first multilingual Indian speech recognition model trained on 65 languages and dialects. It extends ASR to 45 underserved regional languages, potentially benefiting 25 crore people. This marks a major step in inclusive AI for India's linguistic diversity.